Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease

Journal of Virology

Volumn 86, Issue 3, 2012, Pages 1316-1327

  Segundo, Fayna Díaz San ^a,b   Weiss, Marcelo ^a,b   Pérez Martín, Eva ^b   Dias, C Camila ^a,b   Grubman, Marvin J ^a   de los Santos, Teresa ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HUMORAL IMMUNITY; IMMUNE RESPONSE; INNATE IMMUNITY; INOCULATION; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; SAP MUTANT VIRUS; SWINE; SYMPTOMATOLOGY; VIREMIA; VIRUS MUTANT; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; CELL LINE; CRICETINAE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; MUTATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; SWINE DISEASES; T-LYMPHOCYTES; VIRAL VACCINES;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; SUIDAE;

EID: 84857072626     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05941-11     Document Type: Article

References (75)

1. Aravind L, Koonin EV. 2000. SAP-a putative DNA-binding motif involved in chromosomal organization. Trends Biochem. Sci. 25:112-114.
2. Balabanian K, et al. 2002. Interleukin-10 modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite effects on stromal cell-derived factor-1 and B584 lymphocyte chemoattractant. Blood 99: 427-436.
3. Bautista EM, Ferman GS, Golde WT. 2003. Induction of lymphopenia and inhibition of T cell function during acute infection of swine with foot and mouth disease virus (FMDV). Vet. Immunol. Immunopathol. 92: 61-73.
4. Becker Y. 1994. Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)-a point of view. Virus Genes 8:199-214.
5. Belov GA, et al. 2004. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J. Virol. 78:10166-10177.
6. Borrego B, et al. 2006. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Vaccine 24:3889-3899.
7. Bose S, Kar N, Maitra R, DiDonato JA, Benerjee AK. 2003. Temporal activation of NF-kB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses. Proc. Natl. Acad. Sci. U. S. A. 100:10890-10895.
8. Brown CC, Chinsangaram J, Grubman MJ. 2000. Type I interferon production in cattle infected with 2 strains of foot-and-mouth disease virus, as determined by in situ hybridization. Can. J. Vet. Res. 64:130-133.
9. Brown CC, Piccone ME, Mason PW, McKenna TS, Grubman MJ. 1996. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J. Virol. 70:5638-5641.
10. Carrillo C, et al. 2007. Genetic and phenotypic variation of foot-andmouth disease virus during serial passages in a natural host. J. Virol. 81: 11341-11351.
11. Chinsangaram J, Koster M, Grubman MJ. 2001. Inhibition of L-deleted foot-and-mouth disease virus replication by alpha/beta interferon involves double-stranded RNA-dependent protein kinase. J. Virol. 75: 5498-5503.
12. Chinsangaram J, Mason PW, Grubman MJ. 1998. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine 16:1516-1522.
13. Chinsangaram J, Moraes MP, Koster M, Grubman MJ. 2003. A novel viral disease control strategy: adenovirus expressing interferon alpha rapidly protects swine from foot-and-mouth disease. J. Virol. 77:1621-1625.
14. Chinsangaram J, Piccone ME, Grubman MJ. 1999. Ability of foot-andmouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J. Virol. 73:9891-9898.
15. Choe SS, Dodd DA, Kirkegaard K. 2005. Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 337:18-29.
16. Collen T, Pullen L, Doel TR. 1989. T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. J. Gen. Virol. 70:395-403.
17. de Avila Botton S, et al. 2006. Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha. Vaccine 24:3446 -3456.
18. Delhaye S, van Pesch V, Michiels T. 2004. The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J. Virol. 78:4357- 4362.
19. de los Santos T, de Avila Botton S, Weiblen R, Grubman MJ. 2006. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J. Virol. 80:1906-1914.
20. de los Santos T, Díaz-San Segundo F, Grubman MJ. 2007. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J. Virol. 81:12803-12815.
21. de los Santos T, et al. 2009. A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function. J. Virol. 83:1800-1810.
22. Devaney MA, Vakharia VN, Lloyd RE, Ehrenfeld E, Grubman MJ. 1988. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J. Virol. 62: 4407-4409.
23. Dias CCA, Moraes MP, Díaz-San Segundo F, de los Santos T, Grubman MJ. 2011. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus. J. Interferon Cytokine Res. 31:227-236.
24. Díaz-San Segundo F, Moraes MP, de los Santos T, Dias CC, Grubman MJ. 2010. Interferon-induced protection against foot-and-mouth disease virus correlates with enhanced tissue specific innate immune cell infiltration and interferon stimulated gene expression. J. Virol. 84:2063-2077.
25. Díaz-San Segundo F, Rodriguez-Calvo T, de Avila A, Sevilla N. 2009. Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10. PLoS One 4:1-11.
26. Díaz-San Segundo F, et al. 2006. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J. Virol. 80:2369 -2379.
27. Doel TR. 2005. Natural and vaccine induced immunity to FMD. Curr. Top. Microbiol. Immunol. 288:103-131.
28. Escarmís C, et al. 1996. Genetic lesions associated with Muller's ratchet in an RNA virus. J. Mol. Biol. 264:255-267.
29. Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW. 1982. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eukaryotic initiation factor 3 and a cap binding protein complex. J. Biol. Chem. 257:14806 -14810.
30. Fenner F, Henderson DA, Arita I, Jezek Z, Ladnyi ID. 1988. Smallpox and its eradication, 1st ed. World Health Organization, Geneva, Switzerland.
31. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM. 2004. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J. Exp. Med. 199:1607-1618.
32. García-Briones MM, et al. 2004. Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology 322: 264-275.
33. Grubman MJ, Baxt B. 2004. Foot-and-mouth disease. Clin. Microbiol. Rev. 17:465-493.
34. Grubman MJ, Robertson BH, Morgan DO, Moore DM, Dowbenko D. 1984. Biochemical map of polypeptides specified by foot-and-mouth disease virus. J. Virol. 50:579-586.
35. Grubman MJ, Moraes MP, Díaz-San Segundo F, Pena L, de los Santos T. 2008. Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen. FEMS Immunol. Med. Microbiol. 53:8-17.
36. Grubman MJ, et al. 2010. Adenovirus serotype 5-vectored foot-andmouth disease subunit vaccines: the first decade. Future Virol. 5:51- 64.
37. Guzman E, Taylor G, Charleston B, Skinner MA, Ellis SA. 2008. An MHC-restricted CD8+ T-cell response is induced in cattle by foot-andmouth disease virus (FMDV) infection and also following vaccination with inactivated FMDV. J. Gen. Virol. 89:667- 675.
38. Guzman E, Taylor G, Charleston B, Ellis SA. 2010. Induction of a cross-reactive CD8(+) T cell response following foot-and-mouth disease virus vaccination. J. Virol. 84:12375-12384.
39. Helin E, Vainionpaa R, Hyppia T, Julkunen I, Matikainen S. 2001. Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549. Virology 10:1-10.
40. Hiscott J, et al. 1993. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell. Biol. 13:6231-6240.
41. Jang HD, Yoon K, Shin YJ, Kim J, Lee SY. 2004. PIAS3 suppresses NF-k{cyrillic}B mediated transcription by interacting with the p65/RelA subunit. J. Biol. Chem. 279:24873-24880.
42. Kapasi K, Rice GP. 1988. Cytomegalovirus infection of peripheral blood mononuclear cells: effects on interleukin-1 and -2 production and responsiveness. J. Virol. 62:3603-3607.
43. Kishimoto T. 2005. IL-6: from laboratory to bedside. Clin. Rev. Allergy Immunol. 28:177-186.
44. Kopf M, et al. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339 -342.
45. Libermann TA, Baltimore D. 1990. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 10:2327-2334.
46. Lidsky PV, et al. 2006. Nucleocytoplasmic traffic disorder induced by cardioviruses. J. Virol. 80:2705-2717.
47. Lin Y, et al. 2007. Inhibition of interleukin-6 expression by the V protein of parainfluenza virus 5. Virology 368:262-272.
48. Mason PW, Piccone ME, McKenna TS-C, Chinsangaram J, Grubman MJ. 1997. Evaluation of a live-attenuated foot-and-mouth virus as a vaccine candidate. Virology 227:96 -102.
49. McCullough KC, et al. 1992. Protective immune response against footand-mouth disease. J. Virol. 66:1835-1840.
50. Mogensen TH, Paludan SR. 2001. Virus-cell interactions: impact on cytokine production, immune evasion and tumor growth. Eur. Cytokine Netw. 12:382-390.
51. Moraes MP, Mayr GA, Mason PW, Grubman MJ. 2002. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.Vaccine 20:1631-1639.
52. Moraes MP, Chinsangaram J, Brum MCS, Grubman MJ. 2003. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine. Vaccine 22:268-279.
53. Moraes MP, et al. 2007. Enhanced antiviral activity against foot-andmouth disease virus by a combination of type I and II porcine interferons. J. Virol. 81:7124-7135.
54. Murphy EA, et al. 2008. Effect of IL-6 deficiency on susceptibility to HSV-1 respiratory infection and intrinsic macrophage antiviral resistance. J. Interferon Cytokine Res. 28:589-595.
55. Nfon CK, Ferman GS, Toka FN, Gregg DA, Golde WT. 2008. Interferon-alpha production by swine dendritic cells is inhibited during acute infection with foot-and-mouth disease virus. Viral Immunol. 21: 68-77.
56. Normile D. 2008. Rinderpest: driven to extinction. Science 319: 1606-1609.
57. Opal SM, DePalo VA. 2000. Anti-inflammatory cytokines. Chest 117: 1162-1172.
58. Pacheco JM, Arzt J, Rodriguez LL. 2010. Early events in the pathogenesis of foot-and-mouth disease in cattle after controlled aerosol exposure. Vet. J. 183:46 -53.
59. Pahl HL. 1999. Activators and target genes of Rel/NF-kB transcription factors. Oncogene 18:6853- 6866.
60. Palma JP, Kwon D, Clipstone NA, Kim BS. 2003. Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NK-kappaB activation: potential role for the initiation of demyelinating disease. J. Virol. 77:6322- 6332.
61. Papi A, Johnston SL. 1999. Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-_B-mediated transcription. J. Biol. Chem. 274:9707-9720.
62. Patch JR, et al. 2011. Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination. Clin. Vaccine Immunol. 18: 280-288.
63. Pena L, et al. 2008. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine. Vaccine 26:5689 -5699.
64. Piccone ME, Rieder E, Mason PW, Grubman MJ. 1995. The foot-andmouth disease virus leader proteinase gene is not required for viral replication. J. Virol. 69:5376-5382.
65. Reid E, et al. 2011. Bovine plasmacytoid dendritic cells are the major source of type I interferon in response to foot-and-mouth disease virus in vitro and in vivo. J. Virol. 85:4297-4308.
66. Rieder E, Bunch T, Brown F, Mason PW. 1993. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67:5139-5145.
67. Rueckert RR. 1996. Picornaviridae: the viruses and their replication, p 609-654. In Fields BN, Knipe DM, Howley PH (ed), Fields virology, 5th ed. Lippincott-Raven, Philadelphia, PA.
68. Ruggiero V, Antonelli G, Gentile M, Conciatori G, Dianzani F. 1989. Comparative study on the antiviral activity of tumor necrosis factor (TNF)-alpha, lymphotoxin/TNF-beta, and IL-1 in WISH cells. Immunol. Lett. 21:165-169.
69. Salt JS, Barnett PV, Dani P, Williams L. 1998. Emergency vaccination of pigs against foot-and-mouth disease: protection against disease and reduction in contact transmission. Vaccine 16:746-754.
70. Sang Y, Rowland RR, Hesse RA, Blecha F. 2010. Differential expression and activity of the porcine type I interferon family. Physiol. Genomics 42:248-258.
71. 70a.Strebel K, Beck E. 1986. A second protease of foot-and-mouth disease virus. J. Virol. 58:893-899.
72. Su B, et al. 2008. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses toFMDVand maturation of dendritic cells by DNA vaccination. Vaccine 26:5111-5122.
73. Toka FN, Nfon C, Dawson H, Golde WT. 2009. Natural killer cell dysfunction during acute infection with foot-and-mouth disease virus. Clin. Vaccine Immunol. 16:1738-1749.
74. Zhang Z, et al. 2006. Cytokine and Toll-like receptor mRNAs in the nasal-associated lymphoid tissues of cattle during foot-and-mouth disease virus infection. J. Comp. Pathol. 134:56-62.
75. Zhu J, Weiss M, Grubman MJ, de los Santos T. 2010. Differential gene expression in bovine cells infected with wild type and leaderless foot-andmouth disease virus. Virology 404:32-40.